pravastatin

Pravastatin (CS-514) is a competitive HMG-CoA reductase inhibitor with an IC50 of 5.6 μM for sterol synthesis, capable of lowering serum cholesterol.

Pravastatin lactone is a metabolite of pravastatin , a hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor that is a ring-hydroxylated metabolite of mevastatin . Pravastatin lactone is formed when pravastatin undergoes acid-catalyzed non-enzymatic lactonization in the stomach following oral administration.

3α-Hydroxy pravastatin sodium, the primary metabolite of Pravastatin, is a potent competitive inhibitor of HMG-CoA reductase.

Pravastatin sodium (CS-514 (sodium)), an HMG-CoA reductase inhibitor, inhibits sterol synthesis with IC50 of 5.6 μM.

Pravastatin-d3(sodium) is the deuterated form of Pravastatin sodium salt. As a competitive inhibitor of HMG-CoA reductase, Pravastatin (CS-514) sodium salt has an IC50 of 5.6 μM in inhibiting sterol synthesis.

Pravastatin Sodium (Standard) is the standard substance of Pravastatin Sodium, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Pravastatin sodium (CS-514 (sodium)), an HMG-CoA reductase inhibitor, inhibits sterol synthesis with IC50 of 5.6 μM.